Trial Profile
Telaprevir or boceprevir based therapy for chronic hepatitis C infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Boceprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Dec 2015 New trial record